利妥昔单抗治疗自身免疫性细胞减少伴惰性b细胞克隆的持久疗效

IF 10.1 1区医学 Q1 HEMATOLOGY

American Journal of Hematology Pub Date : 2025-07-08 DOI:10.1002/ajh.27754

Yoann Zadro,Amélie Lusque,Héloïse Rey,Pierre Cougoul,Jérémie Dion,Julie Graveleau,Fanny Lemarié,Lenaïg Le Clech,Corentin Orvain,Paul Albert Domnariu,Clément Gourguechon,Étienne Crickx,Kamel Laribi,Delphine Gobert,Léonce Adjoumani,Émilie Berthoux,Alban Deroux,Marie Durel,Mikael Ebbo,Jonathan Farhi,Sébastien Humbert,Vincent Jachiet,Joséphine Thomazeau,Brice Castel,Clément Begey,Jean-Baptiste Rieu,Samuel Deshayes,Mathilde Devaux,Isabelle Durieu,Martin Gauthier,Marion Loirat,Étienne Rivière,Jean-Francois Viallard,Nihal Martis,Pierre-Yves Jeandel,Jérôme Paillassa,Guillaume Denis,Sondess Hadj-Khelifa,Christian Lavigne,François Lifermann,Emmanuel Andrès,Charles Dumontet,Vincent Grobost,Gaétan Sauvetre,Arsène Mekinian,Marc Michel,Bertrand Godeau,Loïc Ysebaert,Guillaume Moulis,Thibault Comont

{"title":"利妥昔单抗治疗自身免疫性细胞减少伴惰性b细胞克隆的持久疗效","authors":"Yoann Zadro,Amélie Lusque,Héloïse Rey,Pierre Cougoul,Jérémie Dion,Julie Graveleau,Fanny Lemarié,Lenaïg Le Clech,Corentin Orvain,Paul Albert Domnariu,Clément Gourguechon,Étienne Crickx,Kamel Laribi,Delphine Gobert,Léonce Adjoumani,Émilie Berthoux,Alban Deroux,Marie Durel,Mikael Ebbo,Jonathan Farhi,Sébastien Humbert,Vincent Jachiet,Joséphine Thomazeau,Brice Castel,Clément Begey,Jean-Baptiste Rieu,Samuel Deshayes,Mathilde Devaux,Isabelle Durieu,Martin Gauthier,Marion Loirat,Étienne Rivière,Jean-Francois Viallard,Nihal Martis,Pierre-Yves Jeandel,Jérôme Paillassa,Guillaume Denis,Sondess Hadj-Khelifa,Christian Lavigne,François Lifermann,Emmanuel Andrès,Charles Dumontet,Vincent Grobost,Gaétan Sauvetre,Arsène Mekinian,Marc Michel,Bertrand Godeau,Loïc Ysebaert,Guillaume Moulis,Thibault Comont","doi":"10.1002/ajh.27754","DOIUrl":null,"url":null,"abstract":"Durable responses with front-line rituximab in autoimmune cytopenias associated with indolent B-Cell clones.","PeriodicalId":7724,"journal":{"name":"American Journal of Hematology","volume":"17 1","pages":""},"PeriodicalIF":10.1000,"publicationDate":"2025-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Durable Responses With Front-Line Rituximab in Autoimmune Cytopenias Associated With Indolent B-Cell Clones.\",\"authors\":\"Yoann Zadro,Amélie Lusque,Héloïse Rey,Pierre Cougoul,Jérémie Dion,Julie Graveleau,Fanny Lemarié,Lenaïg Le Clech,Corentin Orvain,Paul Albert Domnariu,Clément Gourguechon,Étienne Crickx,Kamel Laribi,Delphine Gobert,Léonce Adjoumani,Émilie Berthoux,Alban Deroux,Marie Durel,Mikael Ebbo,Jonathan Farhi,Sébastien Humbert,Vincent Jachiet,Joséphine Thomazeau,Brice Castel,Clément Begey,Jean-Baptiste Rieu,Samuel Deshayes,Mathilde Devaux,Isabelle Durieu,Martin Gauthier,Marion Loirat,Étienne Rivière,Jean-Francois Viallard,Nihal Martis,Pierre-Yves Jeandel,Jérôme Paillassa,Guillaume Denis,Sondess Hadj-Khelifa,Christian Lavigne,François Lifermann,Emmanuel Andrès,Charles Dumontet,Vincent Grobost,Gaétan Sauvetre,Arsène Mekinian,Marc Michel,Bertrand Godeau,Loïc Ysebaert,Guillaume Moulis,Thibault Comont\",\"doi\":\"10.1002/ajh.27754\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Durable responses with front-line rituximab in autoimmune cytopenias associated with indolent B-Cell clones.\",\"PeriodicalId\":7724,\"journal\":{\"name\":\"American Journal of Hematology\",\"volume\":\"17 1\",\"pages\":\"\"},\"PeriodicalIF\":10.1000,\"publicationDate\":\"2025-07-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Hematology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/ajh.27754\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Hematology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/ajh.27754","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

利妥昔单抗治疗与惰性b细胞克隆相关的自身免疫性细胞减少症的持久疗效

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Durable Responses With Front-Line Rituximab in Autoimmune Cytopenias Associated With Indolent B-Cell Clones.

Durable responses with front-line rituximab in autoimmune cytopenias associated with indolent B-Cell clones.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

American Journal of Hematology 医学-血液学

CiteScore

15.70

自引率

3.90%

发文量

363

审稿时长

3-6 weeks

期刊介绍： The American Journal of Hematology offers extensive coverage of experimental and clinical aspects of blood diseases in humans and animal models. The journal publishes original contributions in both non-malignant and malignant hematological diseases, encompassing clinical and basic studies in areas such as hemostasis, thrombosis, immunology, blood banking, and stem cell biology. Clinical translational reports highlighting innovative therapeutic approaches for the diagnosis and treatment of hematological diseases are actively encouraged.The American Journal of Hematology features regular original laboratory and clinical research articles, brief research reports, critical reviews, images in hematology, as well as letters and correspondence.